Intco Medical Technology Co., Ltd. (SHE: 300677)
China
· Delayed Price · Currency is CNY 27.15
-0.84 (-3.00%)
Nov 14, 2024, 3:04 PM CST
Intco Medical Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 8,944 | 6,887 | 6,591 | 16,217 | 13,833 | 2,082 | Upgrade
|
| Other Revenue | 31.36 | 31.36 | 23.21 | 23.28 | 3.42 | 1.15 | Upgrade
|
| Revenue | 8,975 | 6,919 | 6,614 | 16,240 | 13,837 | 2,083 | Upgrade
|
| Revenue Growth (YoY) | 39.29% | 4.61% | -59.27% | 17.37% | 564.29% | 10.06% | Upgrade
|
| Cost of Revenue | 7,094 | 5,991 | 5,776 | 6,267 | 4,292 | 1,562 | Upgrade
|
| Gross Profit | 1,882 | 927.9 | 837.65 | 9,973 | 9,545 | 521.06 | Upgrade
|
| Selling, General & Admin | 748.03 | 723.85 | 614.49 | 929.36 | 567.88 | 217.48 | Upgrade
|
| Research & Development | 375.38 | 283.37 | 252.32 | 365.22 | 293.3 | 67.6 | Upgrade
|
| Other Operating Expenses | 107.02 | 67.29 | 55.39 | 44.07 | 56.04 | 18.44 | Upgrade
|
| Operating Expenses | 1,267 | 1,090 | 907.94 | 1,390 | 927.47 | 304.3 | Upgrade
|
| Operating Income | 614.19 | -162.49 | -70.28 | 8,583 | 8,618 | 216.76 | Upgrade
|
| Interest Expense | -252.31 | -127.74 | -28.46 | -17.61 | -265.41 | -28.06 | Upgrade
|
| Interest & Investment Income | 546.16 | 396.16 | 193.48 | 172.61 | 4.71 | 9.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 133.39 | 133.39 | 548.96 | -103.86 | - | -2 | Upgrade
|
| Other Non Operating Income (Expenses) | -417.18 | -16.42 | -8.61 | -10.45 | -31.97 | -2.67 | Upgrade
|
| EBT Excluding Unusual Items | 624.25 | 222.9 | 635.09 | 8,624 | 8,325 | 193.03 | Upgrade
|
| Gain (Loss) on Sale of Investments | 84.89 | 175.57 | 59.67 | 32.66 | 3.18 | 2.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.18 | 0.21 | 2.37 | 0.38 | 0.02 | -0.05 | Upgrade
|
| Asset Writedown | -22.24 | -21.32 | -26.87 | -29.04 | -2.08 | -0.43 | Upgrade
|
| Other Unusual Items | 94.2 | 65.46 | 34.15 | 21.07 | 20.51 | 8.13 | Upgrade
|
| Pretax Income | 781.28 | 442.82 | 704.41 | 8,649 | 8,347 | 203.27 | Upgrade
|
| Income Tax Expense | 30.69 | 54.75 | 65.07 | 1,185 | 1,342 | 25.01 | Upgrade
|
| Earnings From Continuing Operations | 750.59 | 388.06 | 639.34 | 7,463 | 7,005 | 178.27 | Upgrade
|
| Minority Interest in Earnings | -10.98 | -5.07 | -10.27 | -33.4 | 2.54 | 0.05 | Upgrade
|
| Net Income | 739.61 | 383 | 629.07 | 7,430 | 7,007 | 178.32 | Upgrade
|
| Net Income to Common | 739.61 | 383 | 629.07 | 7,430 | 7,007 | 178.32 | Upgrade
|
| Net Income Growth | 130.14% | -39.12% | -91.53% | 6.04% | 3829.56% | -0.57% | Upgrade
|
| Shares Outstanding (Basic) | 655 | 660 | 662 | 656 | 574 | 526 | Upgrade
|
| Shares Outstanding (Diluted) | 655 | 660 | 662 | 675 | 620 | 544 | Upgrade
|
| Shares Change (YoY) | -1.45% | -0.28% | -1.97% | 9.01% | 13.91% | 3.34% | Upgrade
|
| EPS (Basic) | 1.13 | 0.58 | 0.95 | 11.33 | 12.21 | 0.34 | Upgrade
|
| EPS (Diluted) | 1.13 | 0.58 | 0.95 | 11.00 | 11.31 | 0.33 | Upgrade
|
| EPS Growth | 133.52% | -38.95% | -91.36% | -2.73% | 3349.76% | -3.79% | Upgrade
|
| Free Cash Flow | -1,110 | -936.28 | -649.76 | 3,236 | 5,690 | -206.88 | Upgrade
|
| Free Cash Flow Per Share | -1.70 | -1.42 | -0.98 | 4.79 | 9.18 | -0.38 | Upgrade
|
| Dividend Per Share | 0.130 | 0.080 | 0.099 | 0.625 | 1.852 | 0.056 | Upgrade
|
| Dividend Growth | 31.62% | -19.00% | -84.20% | -66.25% | 3236.76% | -0.18% | Upgrade
|
| Gross Margin | 20.96% | 13.41% | 12.67% | 61.41% | 68.98% | 25.02% | Upgrade
|
| Operating Margin | 6.84% | -2.35% | -1.06% | 52.85% | 62.28% | 10.41% | Upgrade
|
| Profit Margin | 8.24% | 5.54% | 9.51% | 45.75% | 50.64% | 8.56% | Upgrade
|
| Free Cash Flow Margin | -12.37% | -13.53% | -9.82% | 19.93% | 41.12% | -9.93% | Upgrade
|
| EBITDA | 1,395 | 552.5 | 556.79 | 8,950 | 8,758 | 308.96 | Upgrade
|
| EBITDA Margin | 15.54% | 7.99% | 8.42% | 55.11% | 63.29% | 14.83% | Upgrade
|
| D&A For EBITDA | 780.93 | 714.99 | 627.08 | 367.24 | 140.02 | 92.21 | Upgrade
|
| EBIT | 614.19 | -162.49 | -70.28 | 8,583 | 8,618 | 216.76 | Upgrade
|
| EBIT Margin | 6.84% | -2.35% | -1.06% | 52.85% | 62.28% | 10.41% | Upgrade
|
| Effective Tax Rate | 3.93% | 12.36% | 9.24% | 13.70% | 16.08% | 12.30% | Upgrade
|
| Revenue as Reported | 8,975 | 6,919 | 6,614 | 16,240 | 13,837 | 2,083 | Upgrade
|
| Advertising Expenses | - | 32.98 | 17.85 | 91.6 | 54.34 | 6.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.